EP2163642 - Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 24.11.2017 Database last updated on 19.10.2024 | |
Former | Examination is in progress Status updated on 24.03.2017 | Most recent event Tooltip | 24.11.2017 | Application deemed to be withdrawn | published on 27.12.2017 [2017/52] | Applicant(s) | For all designated states M.G.V.S. Ltd. c/o Naiot Technological Center Ltd., P.O. Box 732 Nazareth Illit 17106 / IL | [2010/11] | Inventor(s) | 01 /
Flugelman, Moshe Y. 80 Hanassi Boulevard 34642 Haifa / IL | 02 /
Gluzman, Zoya 528 25167 Tal-El / IL | 03 /
Preis, Meir 42 Rachel Street 34402 Haifa / IL | 04 /
Koren, Belly 20b Afek Street 20692 Yokneam Ilit / IL | 05 /
Cohen, Tzafra 104 Hatishbi Street 34521 Haifa / IL | 06 /
Tsaba, Adili 80a Shoshanat Hacarmel Street 34323 Haifa / IL | 07 /
Weisz, Anat 23 Shoham Street 34679 Haifa / IL | [2010/11] | Representative(s) | Dennemeyer & Associates S.A. Postfach 70 04 25 81304 München / DE | [N/P] |
Former [2012/47] | Dennemeyer & Associates S.A. 55, rue des Bruyères 1274 Howald / LU | ||
Former [2010/11] | Machtalère, Georges, et al Dennemeyer & Associates S.A. 55, rue des Bruyères 1274 Howald / LU | Application number, filing date | 08156995.6 | 08.08.2001 | [2010/11] | Priority number, date | US20000223727P | 08.08.2000 Original published format: US 223727 P | [2010/11] | Previously filed application, date | WO2001IL00733 | 08.08.2001 | [2010/11] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2163642 | Date: | 17.03.2010 | Language: | EN | [2010/11] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 16.02.2010 | Classification | IPC: | C12P21/04, C12N5/071, C07H21/00, A01N43/04, C07K14/52, C07K14/475, C12N15/85, A61K38/18, A61K38/19, C07K14/50, C07K14/495, C07K14/49, C07K14/515, C07K14/575, C12N9/12, C12N15/86, A61K49/00, C07K14/485, A61K48/00 | [2012/31] | CPC: |
A61K49/0056 (EP,US);
A61K48/005 (EP,US);
A61K49/0047 (EP,US);
A61P9/00 (EP);
A61P9/10 (EP);
C07K14/475 (EP,US);
C07K14/485 (EP,US);
C07K14/49 (EP,US);
C07K14/52 (EP,US);
C12N15/86 (EP,US);
C12N2710/10343 (EP,US);
C12N2740/13043 (EP,US);
|
Former IPC [2010/11] | C12P21/04, C12N5/071, C07H21/00, A01N43/04, C07K14/52, C07K14/475, C12N15/85, A61K38/18, A61K38/19, C07K14/50, C07K14/495, C07K14/49, C07K14/515, C07K14/575, C12N9/12 | Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2010/11] | Title | German: | Nukleinsäurekonstrukte, damit transformierte vaskuläre Zellen, pharmezeutische Zusammensetzungen und Verfahren zur Induktion der Angiogenese | [2010/11] | English: | Nucleic acid constructs, vascular cells transformed therewith, pharmaceutical compositions and methods utilizing same for inducing angiogenesis | [2010/11] | French: | Produits de recombinaison d'acide nucléique, cellules vasculaires transformées au moyen de ces produits de recombinaison, compositions pharmaceutiques et procédés les mettant en application afin d'induire l'angiogènese | [2010/11] | Examination procedure | 27.05.2008 | Examination requested [2010/11] | 02.07.2010 | Despatch of a communication from the examining division (Time limit: M04) | 02.11.2010 | Reply to a communication from the examining division | 19.07.2011 | Despatch of a communication from the examining division (Time limit: M04) | 08.09.2011 | Reply to a communication from the examining division | 14.03.2017 | Despatch of a communication from the examining division (Time limit: M04) | 25.07.2017 | Application deemed to be withdrawn, date of legal effect [2017/52] | 21.08.2017 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2017/52] | Parent application(s) Tooltip | EP01958342.6 / EP1307582 | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued (EP20010958342) is 25.04.2005 | Fees paid | Renewal fee | 27.05.2008 | Renewal fee patent year 03 | 27.05.2008 | Renewal fee patent year 04 | 27.05.2008 | Renewal fee patent year 05 | 27.05.2008 | Renewal fee patent year 06 | 27.05.2008 | Renewal fee patent year 07 | 27.05.2008 | Renewal fee patent year 08 | 24.08.2009 | Renewal fee patent year 09 | 25.08.2010 | Renewal fee patent year 10 | 24.08.2011 | Renewal fee patent year 11 | 23.08.2012 | Renewal fee patent year 12 | 23.08.2013 | Renewal fee patent year 13 | 25.08.2014 | Renewal fee patent year 14 | 20.08.2015 | Renewal fee patent year 15 | 22.08.2016 | Renewal fee patent year 16 | Penalty fee | Additional fee for renewal fee | 31.08.2017 | 17   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]US4950483 (KSANDER GEORGE [US], et al) [A] 1-8 * column 8, paragraph 4; claims 1-10 *; | [A]WO0037642 (REGENERON PHARMA [US], et al) [A] 1-8 * page 3 - page 24 *; | [X] - ASAHARA T ET AL, "TIE2 RECEPTOR LIGANDS, ANGIOPOIETIN-1 AND ANGIOPOIETIN-2, MODULATE VEGF-INDUCED POSTNATAL NEOVASCULARIZATION", CIRCULATION RESEARCH, GRUNE AND STRATTON, BALTIMORE, US, (1998), vol. 83, no. 3, ISSN 0009-7330, pages 233 - 240, XP000907290 [X] 1-2 * the whole document * | [X] - THURSTON G ET AL, "Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, (19991224), vol. 286, no. 5449, ISSN 0036-8075, pages 2511 - 2514, XP002357065 [X] 4-6 * the whole document * DOI: http://dx.doi.org/10.1126/science.286.5449.2511 | [A] - JAIN R K ET AL, "Leaky vessels? Call Ang 1!", NATURE MEDICINE, NATURE PUBLISHING, CO, US, (200002), vol. 6, no. 2, ISSN 1078-8956, pages 131 - 132, XP002186836 [A] 1-8 * the whole document * DOI: http://dx.doi.org/10.1038/72212 |